Treatment option...

Comments

  • NewHere
    NewHere Member Posts: 1,427 Member
    Link Worked

    Always good to see something to help with this, but also reading many of these things is a bit of a letdown.  Not to say every bit is not a good thing, but love to see results measured in years ;)  Some of the numbers look okay, but overall not sure.  Will need to go through it again.

     

    In the RECOURSE study, the median overall survival (OS) for patients with refractory metasatic colorectal cancer (mCRC) who received Lonsurf was 7.1 months compared with 5.3 months with placebo. The median progression-free survival (PFS) in the Lonsurf arm was 2 months versus 1.7 months with placebo.

  • janderson1964
    janderson1964 Member Posts: 2,215 Member
    NewHere said:

    Link Worked

    Always good to see something to help with this, but also reading many of these things is a bit of a letdown.  Not to say every bit is not a good thing, but love to see results measured in years ;)  Some of the numbers look okay, but overall not sure.  Will need to go through it again.

     

    In the RECOURSE study, the median overall survival (OS) for patients with refractory metasatic colorectal cancer (mCRC) who received Lonsurf was 7.1 months compared with 5.3 months with placebo. The median progression-free survival (PFS) in the Lonsurf arm was 2 months versus 1.7 months with placebo.

    I know what you mean but they

    I know what you mean but they are statistics and I am sure there are some who have done much better than those numbers in the trials. So there is always that hope that if you need the drug one day that you are one of the patients who have above average response.